These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33571112)

  • 1. Fibrillin-1-enriched microenvironment drives endothelial injury and vascular rarefaction in chronic kidney disease.
    Li L; Liao J; Yuan Q; Hong X; Li J; Peng Y; He M; Zhu H; Zhu M; Hou FF; Fu H; Liu Y
    Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33571112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAS protein activator-like 2 (RASAL2) initiates peritubular capillary rarefaction in hypoxic renal interstitial fibrosis.
    Zhang Y; Yang Y; Hu X; Wei B; Shen Q; Shi C; Chen P
    Transl Res; 2024 Jul; 269():14-30. PubMed ID: 38453052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin-2 inhibition attenuates kidney fibrosis by hindering chemokine C-C motif ligand 2 expression and apoptosis of endothelial cells.
    Chang FC; Liu CH; Luo AJ; Tao-Min Huang T; Tsai MH; Chen YJ; Lai CF; Chiang CK; Lin TH; Chiang WC; Chen YM; Chu TS; Lin SL
    Kidney Int; 2022 Oct; 102(4):780-797. PubMed ID: 35934136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage promotes fibroblast activation and kidney fibrosis by assembling a vitronectin-enriched microenvironment.
    Peng Y; Li L; Shang J; Zhu H; Liao J; Hong X; Hou FF; Fu H; Liu Y
    Theranostics; 2023; 13(11):3897-3913. PubMed ID: 37441594
    [No Abstract]   [Full Text] [Related]  

  • 5. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
    Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases.
    Miao C; Zhu X; Wei X; Long M; Jiang L; Li C; Jin D; Du Y
    Ren Fail; 2022 Dec; 44(1):881-892. PubMed ID: 35618410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGFR2 insufficiency enhances phosphotoxicity and undermines Klotho's protection against peritubular capillary rarefaction and kidney fibrosis.
    Shi M; Maique JO; Cleaver O; Moe OW; Hu MC
    Am J Physiol Renal Physiol; 2023 Jan; 324(1):F106-F123. PubMed ID: 36395384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary rarefaction: a missing link in renal and cardiovascular disease?
    Steegh FMEG; Keijbeck AA; de Hoogt PA; Rademakers T; Houben AJHM; Reesink KD; Stehouwer CDA; Daemen MJAP; Peutz-Kootstra CJ
    Angiogenesis; 2024 Feb; 27(1):23-35. PubMed ID: 37326760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Matrix Analysis of Human Renal Arteries in Both Quiescent and Active Vascular State.
    van Dijk CGM; Louzao-Martinez L; van Mulligen E; Boermans B; Demmers JAA; van den Bosch TPP; Goumans MJ; Duncker DJ; Verhaar MC; Cheng C
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permissive role of vascular endothelium in fibrosis: focus on the kidney.
    Goligorsky MS
    Am J Physiol Cell Physiol; 2024 Mar; 326(3):C712-C723. PubMed ID: 38223932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via αvβ6 integrin signaling.
    Zhu H; Liao J; Zhou X; Hong X; Song D; Hou FF; Liu Y; Fu H
    Kidney Int; 2020 May; 97(5):1017-1031. PubMed ID: 32245660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial sirtuin 1 inactivation enhances capillary rarefaction and fibrosis following kidney injury through Notch activation.
    Kida Y; Zullo JA; Goligorsky MS
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1074-9. PubMed ID: 27524235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis.
    Liu S; Soong Y; Seshan SV; Szeto HH
    Am J Physiol Renal Physiol; 2014 May; 306(9):F970-80. PubMed ID: 24553434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic landscape of the extracellular matrix in the fibrotic kidney.
    Li L; He M; Tang X; Huang J; Li J; Hong X; Fu H; Liu Y
    Kidney Int; 2023 Jun; 103(6):1063-1076. PubMed ID: 36805449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload-Induced Heart Disease.
    Li C; Zhao Y; Li F; Wang Z; Qiu Z; Yang Y; Xiong W; Wang R; Chen H; Xu F; Zang T; Pei Z; Wang Y; Shi B; Shen L; Ge J
    Adv Sci (Weinh); 2023 Jul; 10(21):e2206801. PubMed ID: 37310417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progenitor-like cells derived from mouse kidney protect against renal fibrosis in a remnant kidney model via decreased endothelial mesenchymal transition.
    Chen CL; Chou KJ; Fang HC; Hsu CY; Huang WC; Huang CW; Huang CK; Chen HY; Lee PT
    Stem Cell Res Ther; 2015 Dec; 6():239. PubMed ID: 26631265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astaxanthin ameliorates renal interstitial fibrosis and peritubular capillary rarefaction in unilateral ureteral obstruction.
    Zhao J; Meng M; Zhang J; Li L; Zhu X; Zhang L; Wang C; Gao M
    Mol Med Rep; 2019 Apr; 19(4):3168-3178. PubMed ID: 30816496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fibrillin-1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells.
    Wang Z; Chen W; Zuo L; Xu M; Wu Y; Huang J; Zhang X; Li Y; Wang J; Chen J; Wang H; Sun H
    Cancer Commun (Lond); 2022 Mar; 42(3):245-265. PubMed ID: 35234370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.
    Kida Y; Tchao BN; Yamaguchi I
    Pediatr Nephrol; 2014 Mar; 29(3):333-42. PubMed ID: 23475077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRG1 Mitigates Renal Interstitial Fibrosis through Alleviating Capillary Rarefaction and Inhibiting Inflammatory and Pro-Fibrotic Cytokines.
    Liu TT; Luo R; Yang Y; Cheng YC; Chang D; Dai W; Li YQ; Ge SW; Xu G
    Am J Nephrol; 2021; 52(3):228-238. PubMed ID: 33823527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.